Title: "Evaluation
Of Short-Term (30 Days) Surgical Outcomes Of Laparoscopic Anti-Reflux Surgery :
A Multicentre Prospective Observational Cohort Study In India"
Chief
Investigator: Dr Ramesh Makam (AV Hospital and Arka Anugraha Hospital)
Co- Investigators:
Dr. Ramesh Agarwalla
Dr. Kamal Mahawar
Dr. Tulip Chamany
Dr. Gaurang Ramesh
Dr. Sahana
Manjunath
Dr. Nikhil .M
Dr. Shaik Mohammed
Safiuddin
BACKGROUND:
Hiatal
hernias are herniation of the stomach or other abdominal organs into the chest
through the oesophageal hiatus in the diaphragm. Hiatal hernias have been
associated with gastroesophageal reflux disease (GERD). The typical presentation leading to an
evaluation for a hiatal hernia is gastroesophageal reflux disease (GERD).
Patients typically complain of heartburn and sometimes regurgitation. While
heartburn is the most common complaint, some patients will present with
extra-esophageal symptoms such as a chronic cough or asthma. The
presentation of regurgitation or extra-esophageal symptoms typically is a sign
of disease progression.
The prevalence and size of the hiatal hernia has been described to correlate
with the severity of reflux. The presence of a hiatal hernia has also been
identified in nearly 40% of obese patients. Some of the causes of hiatal
hernias have been attributed to age, stress, and degenerative processes on the
diaphragm.
There are
traditionally four types of hiatal hernias:
·
TYPE
I (SLIDING TYPE): Defined
as a migration of the GEJ into the chest secondary to an attenuated
phrenoesophageal ligament. This is the most common type of hiatal hernia.
·
TYPE
II: True
paraesophageal hernias (PEH), occur when the gastric fundus herniates anterior
to the oesophagus while the GEJ remains in the abdomen.
·
TYPE
III: Hiatal hernias are
a combination of types I and II, in which both the GEJ and the gastric fundus
herniate into the chest.
·
TYPE
IV: Hiatal hernias
occur when not only the stomach, but other abdominal organs such as the colon,
also herniates into the chest through the oesophageal hiatus
The term
giant paraesophageal hernia refers to large hiatal hernias where at least 50%
of the stomach is in the mediastinum or the hernia measures at least 6 cm on
endoscopy.
The actual
prevalence of paraesophageal hernias is not known. The most common hiatal
hernia is type I, which accounts for up to 95% of all hiatal hernias.
Paraesophageal hernias may account for up to 14% of all hiatal hernias, and the
majority of paraesophageal hernias are of the type III variety. These hernias
can be associated with life-threatening complications such as gastric volvulus
leading to necrosis or perforation of the stomach.
NEED FOR STUDY:
The accepted
surgical approaches to hiatus hernia repair include thoracotomy, laparotomy
and, more recently, laparoscopy. While each approach has its particular
advantages, there have, as yet, been no randomized controlled trials to
demonstrate superiority of one technique over the others. Consequently, the
choice of the approach still largely depends on individual surgeon preference
and skills. Laparoscopic hiatus hernia repair has gained prominence as the
surgical technique of choice due to its advantages, such as reduced
postoperative pain, shorter hospital stay, and quicker return to normal
activities when compared to open surgical methods.
Despite these
benefits, there is a notable lack of multicentre, evidence-based research
focused on the short-term surgical outcomes of laparoscopic hiatus hernia
repair in India. Existing studies are often single-centre investigations with
limited sample sizes, which restrict their generalizability. Moreover, India’s
diverse population, varying in age, gender, and socioeconomic status, coupled
with disparities in healthcare access and surgical expertise across different
regions, necessitates a multicentre approach to obtain a more comprehensive
understanding. This study aims to fill this critical gap in the literature by
evaluating the short-term surgical outcomes of laparoscopic hiatus hernia
repair across multiple healthcare centres in India, thereby contributing to the
optimization of surgical protocols and improvement of patient care in this
specific context.
GOAL OF THE STUDY:
The study
aims to assess 30-day morbidity rates of anti-reflux surgery in India according
to the Clavien-Dindo Grade (Annexure-1), identify potential risk factors and
confounding variables related to patient demographics and comorbidities, and
document operative details.
By doing so,
the study seeks to provide a comprehensive, evidence-based framework that can
guide clinical decision-making and policy formulation for the management of
hiatus hernia in India.
OBJECTIVES:
1. The
primary objective is to evaluate 30-day morbidity and mortality of anti-reflux
surgery in India.
2. To
identify potential risk factors associated with 30-day morbidity and mortality.
3. To assess
the incidence and types of different postoperative complications.
4. To analyse
the length of hospital stay and its influencing factors.
5. To
evaluate patient related, disease related, surgeon related factors responsible
for 30 days morbidity and mortality.
MATERIALS AND METHODS:
SOURCE OF DATA:
All adult
patients undergoing elective Laparoscopic Anti-Reflux Surgery in India between
_______ and __________. (6 months from the time of approval of the study)
METHODS OF COLLECTION OF DATA:
A.
Study design: Multicentre
prospective observational cohort study.
B.
Study period: 6 months
C.
Place of study: Hospitals
all over India
D.
Inclusion Criteria:
1. Age 18
years or older.
2. Patients
undergoing elective Anti-Reflux Surgery.
3. Both
primary and recurrent/ complex hiatus hernia without complications.
4.
Willingness to participate, as evidenced by signed informed consent.
E.
Exclusion Criteria:
1. Patient
not willing to give informed consent
2. Revisional
Anti-Reflux Surgery.
3. Emergency
Hiatal Hernia Surgery.
4. Incidental
Hiatal Surgery (for example crural repair with bariatric surgery)
5. Pregnancy
6. Untreated
Oesophageal Motility Disorders
7. Patients
with severe medical conditions and multiple comorbidities.
F.
Methodology:
After
obtaining approval and clearance from the institutional ethics committee, the
patients fulfilling the inclusion criteria will be enrolled for the study after
obtaining informed consent.
This study is
an initiative for research by Indian Association of Gastro Intestinal
Endoscopic Surgeons (IAGES). The study adopts a multicentre prospective
observational cohort design, open to participation from any accredited
laparoscopic surgery centre in India. This open participation model aims to
capture a wide range of surgical practices, healthcare settings, and patient
demographics, thereby enhancing the study’s generalizability.
Google forms
regarding surgeons’ personal details are sent to all members and non-members
across the country. These forms will be filled by those interested to
participate in the study. Excel database sheet will then be sent to these
interested surgeons. Data collected till 6 months will be assessed and all
factors will be studied for statistical significance.
Patient
Recruitment:
Centres will
recruit patients based on the predefined inclusion and exclusion criteria. Each
participating centre will designate a study coordinator responsible for patient
recruitment, informed consent, and data collection.
Data
Collection:
Standardized
electronic data collection forms (either in MS Excel file or Google Forms) will
be employed to ensure uniformity in the data gathered. These forms will capture
information on patient demographics, comorbidities, operative details, and
postoperative complications. Data will be collected at multiple time points:
preoperatively, intraoperatively, and postoperatively up to the 30-day
follow-up.
Data
Management:
A centralized
database will be established to collate and manage data from all participating
centres. Data will be anonymized to maintain patient confidentiality.
Statistical
Analysis:
Data will be
analysed using robust statistical methods suitable for observational data,
including descriptive and inferential statistics. Subgroup analyses will be
conducted based on patient demographics, comorbidities, and operative details
to identify potential risk factors and confounding variables.
A
statistician has been appointed by Indian association of gastrointestinal
surgeons for analysis of data. We set significance at p<0.05. A multivariate
analysis will be done to understand which factors are associated with and/or
predict higher morbidity and mortality.
The article
will be written and sent for publication by the end of 6 months.
Primary
End Point: The primary end
point of this study is to evaluate the 30-day morbidity following laparoscopic
hiatus hernia repair, as assessed by the Clavien-Dindo Grade. This grading
system is a standardized method for classifying surgical complications and
provides a comprehensive framework for evaluating the severity and impact of
postoperative complications. The 30-day timeframe is chosen to focus on
short-term outcomes, which are critical for assessing the immediate success and
safety of the surgical procedure. The Clavien-Dindo Grade will be used to
categorize complications into different grades, ranging from Grade I (minor
complications requiring no treatment) to Grade V (death).
Secondary
End Point: Duration of
procedure, length of stay, procedure specific complication rates such as
bleeding, bowel injury, pneumothorax, solid organ injury and reoperation rates
We will
examine a range of patient specific, surgeon specific, and facility specific
variables to see if they impact total complication rates or severe complication
rates.
Patient
factors like Age, Sex, Body Mass Index, associated comorbidities.
Surgeon
factors: The correlation between the surgeon’s experience level (measured in
years of practice and number of similar procedures performed) and postoperative
complications will be analysed.
Facility
related could be private/academic; rural/urban; small set up (< 50 beds)
/big set up (>50 beds) etc.
Benefits
of this study:
This will be
the first multicentre Indian study on 30 days morbidity and mortality in
Laparoscopic Hiatus hernia repair. It will not only help us to analyse our own
data but will encourage surgeons to maintain data of their patients.
Evidence-Based
Practice: By rigorously evaluating short-term surgical outcomes, the study will
provide valuable evidence that can guide clinical decision-making and treatment
protocols.
Enhanced
Generalizability: The multicentre design, open to any accredited laparoscopic
surgery centre in India, ensures a diverse and representative sample, thereby
enhancing the generalizability of the findings.
Risk Factor
Identification: The study will help identify potential risk factors and
confounding variables, such as patient demographics and comorbidities, which
can be crucial for preoperative planning and patient counselling.
Quality
Improvement: The data collected will serve as a benchmark for quality
improvement initiatives in surgical centres across India. It will help identify
areas where intervention is needed to improve patient outcomes.
Conflict
of Interest: None
Financial
Grants: The funding for
statistical analysis will be taken care by IAGES.
ANNEXURE- 1
Clavien-Dindo classification of surgical complications
|
Grade
|
Definition
|
|
Grade I
|
Any deviation from the normal postoperative course
without the need for pharmacological treatment or surgical, endoscopic, and
radiological interventions
Allowed therapeutic regimens are: drugs as antiemetics,
antipyretics, analgesics, diuretics, electrolytes, and physiotherapy. This
grade also includes wound infections opened at the bedside
|
|
Grade II
|
Requiring pharmacological treatment with drugs other
than such allowed for complications. Blood transfusions and total parenteral
nutrition are also included
|
|
Grade III
|
Requiring surgical, endoscopic or radiological
intervention
|
|
IIIa
|
Intervention not under general anaesthesia
|
|
IIIb
|
Intervention under general anaesthesia
|
|
Grade IV
|
Life-threatening complication (including CNS
complications)* requiring IC/ICU management
|
|
IVa
|
Single organ dysfunction (including dialysis)
|
|
IVb
|
Multiorgan dysfunction
|
|
Grade V
|
Death of a patient
|
|